Dropless vitrectomy eye drops for retinal detachment surgery
Treatments studied
Part of Brain & nervous system clinical trials.
This trial studies a “dropless” method (fewer post-surgery eye drops) after pars plana vitrectomy, a surgery used to repair a retinal detachment. It may help by improving comfort and simplifying recovery for people having this specific type of retinal detachment repair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary rhegmatogenous retinal detachment that may or may not involve the macula (mac-on or mac-off).
- You are scheduled to have pars plana vitrectomy using 23-, 25-, or 27-gauge instruments.
- Your surgery plan does not include cataract removal (lensectomy) or cataract surgery at the same time.
- Your vitrectomy will happen within 7 days of the retinal detachment diagnosis.
- You have not had prior retinal/vitreoretinal surgery in the operated eye (laser treatment is allowed).
- You can use eye drops as needed for recovery (this trial requires you to be able to apply drops).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether netarsudil eye drops can prevent vision-threatening scar tissue (proliferative vitreoretinopathy) after retinal detachment repair. If you are having surgery for a retinal detachment, these drops may reduce the risk of complications.
This trial tests if injecting a medication called methotrexate into the eye during retinal detachment surgery can prevent scar tissue from forming. Scar tissue can sometimes cause the retina to detach again, so this treatment might lower that risk.
This trial compares two types of surgery for people with a retinal detachment who still have their natural lens (no prior cataract surgery). One group gets vitrectomy alone; the other gets vitrectomy plus the lens removed at the same time. The goal is to see which approach leads to better outcomes.
This trial tests a medication called topotecan, which is injected into the eye during surgery to treat a serious scarring condition called proliferative vitreoretinopathy (PVR). It may help prevent the retina from detaching again after surgery for retinal detachment or eye injury.
This trial compares two surgical methods—a new foldable band placed around the eye versus a standard procedure called vitrectomy—to treat retinal detachment when the tear is too complex for a simple sponge. It aims to find which approach gives better results.
This trial compares two methods (laser or freezing) to seal tears in the retina after a procedure to reattach it. It may help people with a specific type of retinal detachment where the tear is in the upper part of the eye.
Hear when a new Rhegmatogenous Retinal Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.